Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease

Alzheimer s & Dementia(2025)10.1002/alz.14499Source: DataRank Database

Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.98)OA: hybridTopics (56)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Amirali Vahid ORCID,Bárbara Avelar‐Pereira ORCID,Elveda Gozdas ORCID,S. M. Hadi Hosseini ORCID,for the Alzheimer's Disease Neuroimaging Initiative

Live enrichment

PubMed:39777850 PMC:PMC11848422 OpenAlex:https://openalex.org/W4406154657

National Institute on Aging

Grant: R01AG073362

National Institute on Aging

Grant: R21AG073973

National Institute on Aging

Grant: R21AG064263

National Institute on Aging

Grant: R01AG072470

National Institute of Mental Health

Grant: R61MH119289

National Institute of Mental Health

Grant: R21MH123873

NIA NIH HHS

Grant: U01 AG024904

FWCI

3.98

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14499

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14499

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.14499

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.14499

journalhttps://doi.org/10.1002/alz.14499

Fields of Study

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and TreatmentsHumansAlzheimer Diseasetau ProteinsAmyloid beta-PeptidesPositron-Emission TomographyMaleFemaleEntorhinal CortexAgedMagnetic Resonance ImagingHippocampusAged, 80 and overBiomarkers

MeSH Terms

AgedAged, 80 and overAlzheimer DiseaseFemaleHippocampusHumansMagnetic Resonance ImagingMaleBiomarkersAmyloid beta-Peptidestau ProteinsEntorhinal CortexPositron-Emission TomographyNeuroimaging

Keywords

Alzheimer's Disease Neuroimaging InitiativeHippocampal formationNeurosciencePositron emission tomographyNeuroimagingEntorhinal cortexStandardized uptake valueNeurodegenerationPsychologyAlzheimer's diseaseCognitive declineMagnetic resonance imagingAmyloid betaMedicineDementiaOncologyCognitionInternal medicineDiseaseCognitive impairmentRadiologyBiomarkersAlzheimer's disease (AD)Positron Emission Tomography (Pet)Amyloid Beta (Aβ)Tau Pathology

Sustainable Development Goals

SDG 0: Good health and well-being